Historical salary details - Dr. Shafique Virani, M.D., Chief Corporate Development Officer, Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
Dr. Shafique Virani, M.D. has been the Chief Corporate Development Officer of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A since 22 Nov 2020. View his historical salary.
Dr. Shafique Virani, M.D.
Chief Corporate Development Officer
-
Gross Remuneration
-
Current Company
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Corporate Development Officer | - | - |
| 2023 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Corporate Development Officer | 2.8 M | 58.6 % |
| 2022 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Corporate Development Officer | 1.8 M | 156.9 % |
| 2021 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | - | 688.2 K | -53.1 % |
| 2021 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Corporate Development Officer | 688.2 K | -53.1 % |
| 2020 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Chief Corporate Development Officer | 1.5 M | - |
| 2020 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | - | 1.5 M | - |
| 2020 | Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | - | 1.5 M | - |